Skip to Content


In the US, Chlorambucil (chlorambucil systemic) is a member of the drug class alkylating agents and is used to treat Cancer, Chronic Lymphocytic Leukemia, Hodgkin's Lymphoma and Lymphoma.

US matches:

UK matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Category

Cytostatic alkylating agent

Chemical Name

Benzenebutanoic acid, 4-[bis(2-chloroetyl)amino]-

Foreign Names

  • Chlorambucilum (Latin)
  • Chlorambucil (German)
  • Chlorambucil (French)
  • Clorambucilo (Spanish)

Generic Names

  • Chlorambucil (OS: BAN, DCF, JAN)
  • Clorambucil (OS: DCIT)
  • CB 1348 (IS)
  • Chlorbutin (IS)
  • CLB (IS)
  • Chlorambucil (PH: BP 2016, Ph. Eur. 8, Ph. Int. 4, USP 38)
  • Chlorambucilum (PH: Ph. Eur. 8, Ph. Int. 4)

Brand Names

  • Chlorambucil Aspen
    Aspen, United Kingdom
  • Chlorambucil SGPharma
    SGPharma, Georgia
  • Chloraminophène
    Techni-Pharma, Monaco
  • Leukeran
    Aspen, Australia; Aspen, Belgium; Aspen, Switzerland; Aspen, Denmark; Aspen, Estonia; Aspen, Ireland; Aspen, Iceland; Aspen, Malta; Aspen, Malaysia; Aspen, Netherlands; Aspen, New Zealand; Aspen, Philippines; Aspen, Poland; Aspen, Portugal; Aspen, Romania; Aspen Europe, Austria; Aspen Labs, Mexico; Aspen Pharma, Germany; Aspen Pharma, Latvia; Aspen Pharma, Norway; Aspen Pharmacare, Hong Kong; Aspri Pharma, Canada; Euro Registratie, Netherlands; Excella, Bulgaria; Excella, Israel; Fisher Farma, Netherlands; Genopharm, Czech Republic; Genopharm, Spain; GlaxoSmithKline, Argentina; GlaxoSmithKline, Bangladesh; GlaxoSmithKline, Brazil; GlaxoSmithKline, China; GlaxoSmithKline, Egypt; GlaxoSmithKline, India; GlaxoSmithKline, Italy; GlaxoSmithKline, Lebanon; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Oman; GlaxoSmithKline, Taiwan; GlaxoSmithKline, United States; GlaxoSmithKline, South Africa; GSK, Turkey; Navamedic, Finland; Pharmatech Chile, Chile; Vitaflo, Sweden; Wael, Bahrain
  • Leukeran Valeant
    Valeant, Latvia


BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.